Regeneron acquires bankrupt 23andMe, pledges ethical use of genetic data
Monday, 19 May 2025 () Regeneron Pharmaceuticals announced on Monday that it will acquire the genetic testing business and most assets of 23andMe for $256 million in cash. The transaction, which excludes 23andMe’s telehealth unit, is pending approval from a bankruptcy court, with the deal expected to close in the third quarter of 2025. The acquisition follows 23andMe’s Chapter 11 […]
Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to... Upworthy
Drugmaker Regeneron Pharmaceuticals says it will comply with privacy policies regarding the use of customer data. 23andMe's bankruptcy filings had drawn scrutiny... Upworthy
Monday, 19 May 2025 ()
